NDC 51808-103

i 123 MIBG meta iodobenzylguanidine

I 123 Mibg

i 123 MIBG meta iodobenzylguanidine is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Iobenguane Sulfate I-123.

Product ID51808-103_ea9f7125-98b5-49c3-85b8-763915156ff0
NDC51808-103
Product TypeHuman Prescription Drug
Proprietary Namei 123 MIBG meta iodobenzylguanidine
Generic NameI 123 Mibg
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2012-05-23
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameAnazaoHealth Corporation
Substance NameIOBENGUANE SULFATE I-123
Active Ingredient Strength25 mCi/1
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 51808-103-01

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CONTAINER (51808-103-01)
Marketing Start Date2012-05-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51808-103-01 [51808010301]

i 123 MIBG meta iodobenzylguanidine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-05-23
Inactivation Date2019-11-13

Drug Details

Active Ingredients

IngredientStrength
IOBENGUANE SULFATE I-12325 mCi/1

OpenFDA Data

SPL SET ID:8fc6228a-faf3-4ba7-80e1-ff56ae934383
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.